Grow applicant sues Maryland Medical Cannabis Commission

A marijuana cultivation company that was bumped from among the initial 15 winning applicants for a Maryland grower’s license is suing the state’s Medical Cannabis Commission.

The case could further delay the rollout of the Maryland medical marijuana program, which already is several months behind its originally anticipated launch.

The commission said it bumped GTI Maryland in a bid to broaden the geographic diversity of the state’s MMJ program, as required by law, the Baltimore Sun reported.

GTI Maryland originally was among the top 15 applicants for a grower license, but it was the lowest-ranking applicant of three companies that applied for licenses in Washington County, in the western part of the state. Given its No. 3 ranking in the county, the company was dropped from the winning group.

Another company, Maryland Cultivation and Processing, was the lowest of three original winners in Frederick County, in the northern part of the state, and also was bumped from the winners’ group.

The two companies moved into the group of winning applicants were Shore Natural Rx and Holistic Industries.

Ten of the original 15 winners were from the north-central part of the state, while the southern and western parts of the state were left underserved, according to The Washington Post.

“This is a case about a state commission setting rules and then inexplicably failing to follow them,” said Philip M. Andrews, a Baltimore lawyer representing GTI Maryland.

Daily News | Briefs | Cultivation | Legal & Regulatory News for Marijuana Businesses | Maryland Medical Cannabis Business & Marijuana Legal News

 4 Comments

  1. Shelley September 20, 2016
    • Cliff September 21, 2016
  2. William W. West September 20, 2016
  3. Dave September 21, 2016

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.